Teva Pharm Expects To Start Paying U.S. Opioid Settlement In 2023
By Steven Scheer TEL AVIV (Reuters) – Teva Pharmaceutical Industries expects to finalise an opioid settlement in the United States by year-end and start paying in 2023, its chief executive said on Sunday, while also questioning the company’s very low share price. After years of negotiations, Israel-based Teva in July proposed a $4.35 billion nationwide…
